🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Sun Pharmaceutical Industries Limited (NSE:SUNPHARMA)
India flag India · Delayed Price · Currency is INR
1,871.50
+1.50 (0.08%)
Nov 18, 2026, 3:28 PM IST

NSE:SUNPHARMA Cash Flow Statement

Millions INR. Fiscal year is Apr - Mar.

Operating Activities

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Net Income
109,662114,794109,29095,76484,73632,727
Depreciation & Amortization
29,36228,69225,07324,90624,77121,090
Other Amortization
686.5686.5681.2661.7533.4435.8
Loss (Gain) From Sale of Assets
-260.21,773235.31,662227.11,656
Asset Writedown & Restructuring Costs
----1.5-10-88.7
Loss (Gain) From Sale of Investments
-10,503-8,636-2,514-921.96.23,126
Provision & Write-off of Bad Debts
49634.11,808905.92,071175.7
Other Operating Activities
914.1-1,0749,383-12,248-6,12215,133
Change in Accounts Receivable
-26,146-20,088-16,0213,529-9,532-13,423
Change in Inventory
-13,331-523-1,8405,988-12,0223,070
Change in Accounts Payable
6,06110,5745,2802,49711,8243,699
Change in Other Net Operating Assets
11,301-2,6419,345-1,393-46,88822,244
Operating Cash Flow
107,795124,192140,721121,35049,59389,845
Operating Cash Flow Growth
-14.13%-11.75%15.96%144.69%-44.80%45.61%

Investing Activities

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Capital Expenditures
-30,060-36,094-21,286-22,018-20,856-14,950
Sale of Property, Plant & Equipment
1,334961.2610.1308.4210.1606.1
Cash Acquisitions
-2,877-34,051-2,728-1,433-46,858-7,396
Divestitures
-----238.4
Investment in Securities
60,093-51,897-38,6429,325-16,436-37,911
Other Investing Activities
8,0447,6418,6987,1234,5032,101
Investing Cash Flow
36,533-113,441-53,062-6,902-79,437-57,247

Financing Activities

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Short-Term Debt Issued
-1,199-1,430-1,064
Long-Term Debt Issued
-52,02233,61745,72781,59816,568
Total Debt Issued
23,92053,22133,61747,15781,59817,632
Short-Term Debt Repaid
---482--1,305-
Long-Term Debt Repaid
--35,616-44,784-82,287-30,010-45,286
Lease Payments
-1,474-1,514-1,345-1,231-1,014-1,287
Total Debt Repaid
-47,586-35,616-45,266-82,287-31,315-45,286
Net Debt Issued (Repaid)
-23,66517,605-11,649-35,13050,283-27,654
Common Dividends Paid
-38,139-39,339-36,140-28,982-25,189-21,589
Other Financing Activities
-3,703-3,392-31,270-2,990-1,333-2,692
Financing Cash Flow
-65,507-25,126-79,058-67,10223,761-51,935

Net Cash Flow

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Foreign Exchange Rate Adjustments
4,8007,7641,230-739.91,5711,274
Miscellaneous Cash Flow Adjustments
166.31,627-0.312.95,667414.5
Net Cash Flow
83,787-4,9839,83146,6191,155-17,648

Free Cash Flow

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Free Cash Flow
77,73588,098119,43599,33228,73874,895
Free Cash Flow Growth
-11.00%-26.24%20.24%245.65%-61.63%49.78%
Free Cash Flow Margin
12.61%15.07%22.72%20.48%6.55%19.38%
Free Cash Flow Per Share
32.4336.7249.7841.4011.9831.21
Levered Free Cash Flow
75,42959,48482,39775,8287,91175,693
Unlevered Free Cash Flow
77,54661,60283,84377,3188,98676,489
Free Cash Flow After Leases
76,26186,584118,09098,10127,72473,609

Additional Metrics

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash Interest Paid
3,2973,3152,2382,1901,325732.1
Cash Income Tax Paid
32,24823,1394,76815,69415,098-9,692
Change in Working Capital
-22,115-12,678-3,23610,621-56,61815,591